NO308583B1 - Anvendelse av steroider for fremstilling av et medikament for behandling av forstyrrelser indusert av østrogenmangel, steroidene samt farmasøytisk blanding - Google Patents
Anvendelse av steroider for fremstilling av et medikament for behandling av forstyrrelser indusert av østrogenmangel, steroidene samt farmasøytisk blandingInfo
- Publication number
- NO308583B1 NO308583B1 NO953089A NO953089A NO308583B1 NO 308583 B1 NO308583 B1 NO 308583B1 NO 953089 A NO953089 A NO 953089A NO 953089 A NO953089 A NO 953089A NO 308583 B1 NO308583 B1 NO 308583B1
- Authority
- NO
- Norway
- Prior art keywords
- steroids
- medicament
- manufacture
- treatment
- well
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/008—Ketals at position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
- C07J33/007—Cyclic thioketals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93200332 | 1993-02-08 | ||
PCT/EP1994/000348 WO1994018224A1 (en) | 1993-02-08 | 1994-02-04 | Steroids for treating menopausal complaints |
Publications (3)
Publication Number | Publication Date |
---|---|
NO953089D0 NO953089D0 (no) | 1995-08-07 |
NO953089L NO953089L (no) | 1995-10-06 |
NO308583B1 true NO308583B1 (no) | 2000-10-02 |
Family
ID=8213615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO953089A NO308583B1 (no) | 1993-02-08 | 1995-08-07 | Anvendelse av steroider for fremstilling av et medikament for behandling av forstyrrelser indusert av østrogenmangel, steroidene samt farmasøytisk blanding |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0682672A1 (xx) |
JP (1) | JPH08506116A (xx) |
KR (1) | KR100364113B1 (xx) |
CN (1) | CN1046735C (xx) |
AU (1) | AU4675897A (xx) |
BR (1) | BR9405825A (xx) |
CA (1) | CA2155532A1 (xx) |
FI (1) | FI114101B (xx) |
HU (2) | HU220615B1 (xx) |
NO (1) | NO308583B1 (xx) |
NZ (1) | NZ261581A (xx) |
PL (1) | PL182901B1 (xx) |
RU (1) | RU2172740C2 (xx) |
WO (1) | WO1994018224A1 (xx) |
ZA (1) | ZA94715B (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL123195A (en) * | 1997-02-21 | 2002-11-10 | Akzo Nobel Nv | Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them |
BR9908605A (pt) * | 1998-03-09 | 2001-04-24 | Akzo Nobel Nv | Kit anticoncepcional, uso de um composto esteróide, e, processo de contracepção |
EP1224204B1 (en) * | 1999-09-06 | 2005-05-18 | Akzo Nobel N.V. | Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
CN1220696C (zh) | 2000-07-28 | 2005-09-28 | 阿克佐诺贝尔公司 | 16α-甲基或乙基取代的雌激素 |
UA89964C2 (ru) | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ |
EP3423464B1 (en) * | 2016-03-03 | 2021-05-26 | Crystal Pharma, S.A.U. | Process and new intermediates for the preparation of 11-methylene steroids |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3325520A (en) * | 1965-12-08 | 1967-06-13 | Searle & Co | (optionally 17-hydrocarbon-substituted) 11, 13beta-dialkylgon-4-en-3-ones and esters corresponding |
US3465010A (en) * | 1966-11-22 | 1969-09-02 | Searle & Co | 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof |
FI54128C (fi) * | 1972-12-09 | 1978-10-10 | Akzo Nv | Foerfarande foer framstaellning av nya 11,11-alkylidensteroider ur oestran- och 19-norpregnanserien med foerbaettrad hormonell verkan |
NL175063C (nl) * | 1972-12-09 | 1984-09-17 | Akzo Nv | Werkwijze ter bereiding van 11,11-alkylideensteroiden, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten. |
NL7317358A (nl) * | 1973-12-19 | 1975-06-23 | Akzo Nv | Nieuwe 11(beta)-alkylsteroiden van de oestraanreeks. |
NL7701384A (nl) * | 1977-02-10 | 1978-08-14 | Akzo Nv | Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks. |
AU532512B2 (en) * | 1979-09-07 | 1983-10-06 | Upjohn and Horton | Anti-allergenic compounds for bone mineral resorption |
US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
AU572589B2 (en) * | 1983-12-14 | 1988-05-12 | Upjohn Company, The | 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids |
NL8502571A (nl) * | 1985-09-20 | 1987-04-16 | Akzo Nv | Steroiden met immunomodulerende eigenschappen. |
DE3702383A1 (de) * | 1987-01-23 | 1988-08-04 | Schering Ag | 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate |
HUT52382A (en) * | 1988-03-14 | 1990-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case |
ATE99939T1 (de) * | 1990-06-14 | 1994-01-15 | Henning Berlin Gmbh | Fluessig befuellte steckkapselpraeparate. |
AU8166191A (en) * | 1990-08-10 | 1992-02-13 | Ortho Pharmaceutical Corporation | Method for treatment of bone wasting diseases |
-
1994
- 1994-02-02 ZA ZA94715A patent/ZA94715B/xx unknown
- 1994-02-04 PL PL94310125A patent/PL182901B1/pl not_active IP Right Cessation
- 1994-02-04 BR BR9405825A patent/BR9405825A/pt not_active Application Discontinuation
- 1994-02-04 KR KR1019950703263A patent/KR100364113B1/ko not_active IP Right Cessation
- 1994-02-04 JP JP6517652A patent/JPH08506116A/ja active Pending
- 1994-02-04 WO PCT/EP1994/000348 patent/WO1994018224A1/en not_active Application Discontinuation
- 1994-02-04 RU RU95118286/04A patent/RU2172740C2/ru not_active IP Right Cessation
- 1994-02-04 CA CA002155532A patent/CA2155532A1/en not_active Abandoned
- 1994-02-04 NZ NZ261581A patent/NZ261581A/en unknown
- 1994-02-04 HU HU9501940A patent/HU220615B1/hu not_active IP Right Cessation
- 1994-02-04 EP EP94906918A patent/EP0682672A1/en not_active Withdrawn
- 1994-02-04 HU HU0102320A patent/HU0102320D0/hu unknown
- 1994-02-04 CN CN94191126A patent/CN1046735C/zh not_active Expired - Fee Related
-
1995
- 1995-08-07 FI FI953747A patent/FI114101B/fi not_active IP Right Cessation
- 1995-08-07 NO NO953089A patent/NO308583B1/no unknown
-
1997
- 1997-11-28 AU AU46758/97A patent/AU4675897A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BR9405825A (pt) | 1995-12-05 |
FI953747A0 (fi) | 1995-08-07 |
AU682170B2 (en) | 1997-09-25 |
PL310125A1 (en) | 1995-11-27 |
FI953747A (fi) | 1995-09-12 |
FI114101B (fi) | 2004-08-13 |
ZA94715B (en) | 1994-10-24 |
NO953089D0 (no) | 1995-08-07 |
AU4675897A (en) | 1998-02-19 |
PL182901B1 (pl) | 2002-03-29 |
CN1046735C (zh) | 1999-11-24 |
AU6039494A (en) | 1994-08-29 |
JPH08506116A (ja) | 1996-07-02 |
HU0102320D0 (en) | 2001-08-28 |
HUT72971A (en) | 1996-06-28 |
WO1994018224A1 (en) | 1994-08-18 |
NZ261581A (en) | 1997-06-24 |
EP0682672A1 (en) | 1995-11-22 |
HU220615B1 (hu) | 2002-03-28 |
CN1117735A (zh) | 1996-02-28 |
KR100364113B1 (ko) | 2003-04-08 |
CA2155532A1 (en) | 1994-08-18 |
HU9501940D0 (en) | 1995-09-28 |
RU2172740C2 (ru) | 2001-08-27 |
NO953089L (no) | 1995-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO971816D0 (no) | Farmasöytisk blanding for behandling av sykdommer forårsaket av IL-6 produksjon | |
AU7289694A (en) | Three part device for the transdermic administration of drugs by electrophoresis or iontophoresis | |
FI946173A0 (fi) | Menetelmä lääkeaineiden antotehon parantamiseksi muunnettujen saponiinien avulla | |
ZA965752B (en) | Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents. | |
NO995245L (no) | Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering | |
CA2166332A1 (en) | Antiglucocorticoid steroids for the treatment of anxiety disorders | |
FR2707087B1 (fr) | Nouveau procédé de préparation de l'ergothionéine. | |
NO953254D0 (no) | Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter | |
NO965444D0 (no) | Triterpen-derivat samt medikamentell sammensetning omfattende dette | |
NO953200D0 (no) | Terapeutisk plantemateriale, samt fremstilling derav | |
AU4530989A (en) | Pharmaceutical composition for the treatment of cerebral edema | |
AU9173191A (en) | Medicaments for the treatment of papillomavirus diseases | |
EP0434571A3 (en) | New steroid derivatives with a substituted ethyl group on the position 10, process for their production, their use as medicines and pharmaceutical compositions containing them | |
NO308583B1 (no) | Anvendelse av steroider for fremstilling av et medikament for behandling av forstyrrelser indusert av østrogenmangel, steroidene samt farmasøytisk blanding | |
NO941659L (no) | Fremgangsmåte for fremstilling av aluminoksaner | |
DK0719276T3 (da) | Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf | |
AU7812794A (en) | Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract | |
NO974569D0 (no) | Benzamider for behandling av neurodegenerative forstyrrelser | |
NO901102D0 (no) | Fremgangsmaate for fremstilling av nye steroidderivater. | |
AU5992990A (en) | 14,17alpha-etheno- and -ethanoestratrienes, processes for the preparation of these compounds, as well as their use for the production of medicinal agents | |
NO913162D0 (no) | Farmasoeytisk preparat for behandling av tonsillitt. | |
NO942973D0 (no) | Fremgangsmåte for opparbeidelse av tynnsyre | |
NO950223D0 (no) | Fremgangsmåte for fremstilling av kjeks, samt slik kjeks | |
WO1995022544A3 (de) | Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika | |
SI0778025T1 (en) | Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals |